These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27905012)

  • 1. Microbial Proteins as Novel Industrial Biotechnology Hosts to Treat Epilepsy.
    Amtul Z; Aziz AA
    Mol Neurobiol; 2017 Dec; 54(10):8211-8224. PubMed ID: 27905012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optogenetic tools for modulating and probing the epileptic network.
    Zhao M; Alleva R; Ma H; Daniel AG; Schwartz TH
    Epilepsy Res; 2015 Oct; 116():15-26. PubMed ID: 26354163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WONOEP appraisal: optogenetic tools to suppress seizures and explore the mechanisms of epileptogenesis.
    Mantoan Ritter L; Golshani P; Takahashi K; Dufour S; Valiante T; Kokaia M
    Epilepsia; 2014 Nov; 55(11):1693-702. PubMed ID: 25303540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optogenetic and chemogenetic therapies for epilepsy.
    Walker MC; Kullmann DM
    Neuropharmacology; 2020 May; 168():107751. PubMed ID: 31494141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Channelrhodopsin-1 Phosphorylation Changes with Phototactic Behavior and Responds to Physiological Stimuli in
    Böhm M; Boness D; Fantisch E; Erhard H; Frauenholz J; Kowalzyk Z; Marcinkowski N; Kateriya S; Hegemann P; Kreimer G
    Plant Cell; 2019 Apr; 31(4):886-910. PubMed ID: 30862615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a highly efficient blue-shifted channelrhodopsin from the marine alga Platymonas subcordiformis.
    Govorunova EG; Sineshchekov OA; Li H; Janz R; Spudich JL
    J Biol Chem; 2013 Oct; 288(41):29911-22. PubMed ID: 23995841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational changes of channelrhodopsin-2.
    Radu I; Bamann C; Nack M; Nagel G; Bamberg E; Heberle J
    J Am Chem Soc; 2009 Jun; 131(21):7313-9. PubMed ID: 19422231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Channelrhodopsin-mediated optogenetics highlights a central role of depolarization-dependent plant proton pumps.
    Reyer A; Häßler M; Scherzer S; Huang S; Pedersen JT; Al-Rascheid KAS; Bamberg E; Palmgren M; Dreyer I; Nagel G; Hedrich R; Becker D
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20920-20925. PubMed ID: 32788371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Channelrhodopsin-1: a light-gated proton channel in green algae.
    Nagel G; Ollig D; Fuhrmann M; Kateriya S; Musti AM; Bamberg E; Hegemann P
    Science; 2002 Jun; 296(5577):2395-8. PubMed ID: 12089443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optogenetics for controlling seizure circuits for translational approaches.
    Ledri M; Andersson M; Wickham J; Kokaia M
    Neurobiol Dis; 2023 Aug; 184():106234. PubMed ID: 37479090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Arg123 in light-driven anion pump mechanisms of pharaonis halorhodopsin.
    Kubo M; Kikukawa T; Miyauchi S; Seki A; Kamiya M; Aizawa T; Kawano K; Kamo N; Demura M
    Photochem Photobiol; 2009; 85(2):547-55. PubMed ID: 19267875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Seizure-Susceptibility in a
    Saras A; Wu VV; Brawer HJ; Tanouye MA
    Genetics; 2017 Aug; 206(4):1739-1746. PubMed ID: 28630111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optogenetic control of astrocytes: is it possible to treat astrocyte-related epilepsy?
    Ji ZG; Wang H
    Brain Res Bull; 2015 Jan; 110():20-5. PubMed ID: 25451697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optogenetics in epilepsy.
    Bentley JN; Chestek C; Stacey WC; Patil PG
    Neurosurg Focus; 2013 Jun; 34(6):E4. PubMed ID: 23724838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glu 87 of channelrhodopsin-1 causes pH-dependent color tuning and fast photocurrent inactivation.
    Tsunoda SP; Hegemann P
    Photochem Photobiol; 2009; 85(2):564-9. PubMed ID: 19192197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An engineered membrane-bound guanylyl cyclase with light-switchable activity.
    Tian Y; Nagel G; Gao S
    BMC Biol; 2021 Mar; 19(1):54. PubMed ID: 33775243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the Cl--pumping photocycle of pharaonis halorhodopsin: Examinations with bacterioruberin, an intrinsic dye, and membrane potential-induced modulation of the photocycle.
    Kikukawa T; Kusakabe C; Kokubo A; Tsukamoto T; Kamiya M; Aizawa T; Ihara K; Kamo N; Demura M
    Biochim Biophys Acta; 2015 Aug; 1847(8):748-58. PubMed ID: 25960108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized photo-stimulation of halorhodopsin for long-term neuronal inhibition.
    Zhang C; Yang S; Flossmann T; Gao S; Witte OW; Nagel G; Holthoff K; Kirmse K
    BMC Biol; 2019 Nov; 17(1):95. PubMed ID: 31775747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optogenetic approaches to treat epilepsy.
    Wykes RC; Kullmann DM; Pavlov I; Magloire V
    J Neurosci Methods; 2016 Feb; 260():215-20. PubMed ID: 26072246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-component cyclase opsins of green algae are ATP-dependent and light-inhibited guanylyl cyclases.
    Tian Y; Gao S; von der Heyde EL; Hallmann A; Nagel G
    BMC Biol; 2018 Dec; 16(1):144. PubMed ID: 30522480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.